Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CNMD · against 460 other Healthcare companies of similar size
Ranked #368 of 461 · scores higher than 20% of peers · safety percentile 20
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)33 peers with a safety percentile of 20–29, including CNMD · Click a bar to see the companies
Mainly because of its debt / equity, current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | CNMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 437 reported | 0.80× | 0.22× | 20% | 33% | |
| BetaLower is better · 433 reported | 0.94 | 0.50 | 27% | 33% | |
| Current ratioHigher is better · 448 reported | 1.48× | 2.83× | 24% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 1.1B USD | 100 | ||
| 5 | 1.0B USD | 99 | 35 | |
| 364 | 11.6B HKD (≈$1.5B) | 23 | 36 | |
| 365 | 1.4B USD | 22 | 53 | |
| 366 | 1.8B USD | 22 | 63 | |
| 367 | 2.0B USD | 21 | 29 | |
| 368 | 1.4B USD | 20 | 42 | |
| 369 | 1.2B USD | 20 | 75 | |
| 370 | 168.6B INR (≈$2.0B) | 20 | 63 | |
| 371 | 133.4B JPY (≈$907M) | 19 | 53 | |
| 372 | 1.5B USD | 19 | 26 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score